Categories: Entertainment

Clarivate Unveils the 2025 Journal Citation Reports

50th Anniversary Year Sees Strengthened Focus on Research Integrity

- Advertisement -

LONDON, June 18, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world’s leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals’ trustworthiness and impact.

- Advertisement -

Only journals that have met the rigorous quality standards for inclusion in the Web of Science Core Collection are featured within the Journal Citation Reports, which ensures users can confidently rely on the information and descriptive data provided. The annual reports provide a rich array of publisher–neutral data, metrics, and analysis to enhance user understanding of journal performance, including the widely recognized Journal Impact Factor (JIF) and the Journal Citation Indicator.

- Advertisement -

Key highlights for the 2025 release:

- Advertisement -
  • The JCR includes data from a total of 22,249 journals across 254 categories
  • Over 6,200 of these were published via gold open access
  • Scholarly journals from 111 countries are recognized and receive a JIF, including 14,591 in the sciences and 7,559 in the social sciences, as well as 3,368 journals in the arts and humanities
  • 618 journals receive a JIF for the first time
  • This year’s release excludes citations to and from retracted content when calculating the JIF numerator, ensuring that citations from retracted articles do not contribute to the numerical value of the JIF. However, retracted articles will still be included in the article count (JIF denominator), maintaining transparency and accountability. This policy affects 1% of journals.

Dr. Nandita Quaderi, Senior Vice President & Editor-in-Chief, Web of Science, Clarivate, said: “We are proud to remain true to our heritage while adapting to changes in the scholarly landscape. As we celebrate the 50th anniversary of the JCR, we are embracing our founder Eugene Garfield’s vision and looking to the future, reinforcing our dedication to maintaining the integrity of the scientific record and continuing our journey towards a more equitable, transparent and trustworthy scholarly ecosystem.”

- Advertisement -

Emmanuel Thiveaud, Senior Vice President, Research and Analytics, Academia & Government at Clarivate said: “We are excited to present the 2025 edition of the Journal Citation Reports, which continues to serve as a vital tool for the global research community. These valuable data and insights empower researchers and institutions to make informed decisions, fostering the advancement of knowledge and innovation.”

- Advertisement -

To explore all available data, metrics and analysis visit the Journal Citation Reports.

- Advertisement -

For more detailed information on this year’s changes, please see our blog.

- Advertisement -

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

- Advertisement -

Media Contact:
Amy Bourke-Waite, Senior Director, External Communications
newsroom@clarivate.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-unveils-the-2025-journal-citation-reports-302483926.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago